Matches 1 - 50 out of 63 1 2 >


Match Document Document Title
US20130230604 ORAL IRON DEFICIENCY THERAPY  
Methods of normalizing iron levels, treating iron deficiency and disorders related thereto, such as anemia, as described. Pharmaceutical compositions effective for such treatments are also described.
US20110002881 TREATMENT AND PROPHYLAXIS  
This invention discloses the use of an E-selectin antagonist in methods and compositions for treating or preventing immunocompromised conditions resulting from medical treatment. The present...
US20110020270 TREATMENT AND PROPHYLAXIS  
This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing...
US20110183009 Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity  
The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered...
US20130259954 Liquid for Treatment of Citrus Greening Disease and Treatment Method Using Same  
Provided are: a liquid for treatment of Citrus greening disease, which is capable of curing citrus trees with Citrus greening disease; and a treatment method using the liquid. The liquid for...
US20150202224 METHOD OF TREATING IRON DEFICIENCY ANEMIA  
Methods for predicting responsiveness of a subject to iron therapy and treatment methods related thereto. Such methods can be useful with respect to conditions, disorders, or diseases associated...
US20110244057 COMBINATION THERAPIES WITH TOPIRAMATE FOR SEIZURES, RESTLESS LEGS SYNDROME, AND OTHER NEUROLOGICAL CONDITIONS  
The invention provides compositions and methods of treating various conditions, including neurological conditions, with pharmaceutical compositions including a sulfamate (e.g., topiramate) and...
US20120093910 NON-HORMONAL VAGINAL CONTRACEPTIVE  
The present invention relates to a non-hormonal, biocompatible, and biodegradable intravaginal device for the delivery of spermiostatic, spermicidal and anti-infectious agents. The present...
US20090297628 Use of iron in the form of a stone extract as stimulus of the synthesis of collagen by skin fibroblasts  
Use of a stone extract as stimulant of the synthesis of collagen by skin fibroblasts.
US20140343480 SYSTEMS, METHODS, AND COMPOSITIONS FOR CROSS-LINKING  
Various agents and additives for cross-linking treatments are identified in disclosed studies. The characteristics of the various agents and additives may be advantageously employed in...
US20110305774 TREATMENT OF RETROVIRAL RESERVOIRS EXPLOITING OXIDATIVE STRESS  
Activation of HIV-1 replication causes oxidative stress, which in turn potentiates HIV-1 replication. The common basis for the compounds of the present invention is: A) the capacity of...
US20130011495 ANTIFUNGAL COMPOUNDS AND USE THEREOF  
The present invention relates to an antifungal composition including at least two compounds selected from among the group consisting of cysteine, salicylic acid, iron(II) sulfate and...
US20110052722 Toleration Iron Supplement Compositions  
The invention relates to compositions and methods for the treatment or prophylaxis of iron deficiency, and in particular of iron deficiency anemia, by administering a composition containing an...
US20100317519 Mixtures and methods for the induction of resistance in plants  
Mixtures are described comprising two or more compounds selected from at least two of the following groups: i) salicylic acid and/or its functional analogous products (ESA), ii) promoting...
US20100266647 Optical Blurring Pigment Composition Suitable for Use in Cosmetics  
Compositions comprising a gel system made from a combination of a fractal network of nanoparticles and translucent macroscopic particles, titanium dioxide and other color pigments is disclosed....
US20120100119 HYDROLYSIS RESISTANT ORGANOMODIFIED TRISILOXANE SURFACTANTS  
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide...
US20120064052 Hydrolysis Resistant Organomodified Trisiloxane Surfactants  
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide...
US20110251067 Hydrolysis Resistant Organomodified Trisiloxane Surfactants  
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide...
US20130309380 METHODS FOR PRESERVING FRESH PRODUCE  
Methods of preserving fresh produce with a produce preservative which extends the shelf life of fresh produce, particularly cut fresh produce, and preserves the texture, flavor, appearance,...
US20130129810 IRON OXIDE NANOPARTICLES FOR USE IN TREATING NON-INFECTIOUS INFLAMMATORY DISORDERS  
In accordance with the present disclosure there are provided iron oxide nanoparticles for use in the treatment of non-infectious inflammatory disorders. Also provided by the present disclosure is...
US20130295197 Formed lyocell articles for selective binding of monovalent heavy metal ions, especially thallium and cesium ions and radioactive isotopes thereof  
Shaped lyocell cellulose articles are provided for binding heavy metal ions and radioactive isotopes thereof. The shaped articles include one or more hexacyanoferrates that are incorporated in a...
US20130243720 Iron(II)-Containing A Treatments for Hyperphosphatemia  
A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable...
US20140234437 IRON SUPPLEMENT COMPOSITION  
In one of its aspects, the present invention provides a composition comprising: (i) a non-encapsulated iron salt, and (ii) a carrier comprising digestible edible oil that is a liquid at 20° C....
US20130209577 Buffered Upper GI Absorption Promoter  
The present invention relates to compositions of an active pharmaceutical compound or nutritional ingredient with one or more buffering agents between a pH of 1.0 and 6.0, preferably 2.0 and 4.0....
US20130323325 COMPOSITION COMPRISING MIXED METAL COMPOUNDS AND XANTHAN GUM  
The present invention provides a composition comprising (i) a mixed metal compound containing at least one trivalent metal selected from iron (lll) and aluminium and at least one divalent metal...
US20110195108 ANTIVIRAL AGENT  
An antiviral agent is provided which can inactivate a wide range of viruses. Products that include such an antiviral agent are also provided. The present invention provides an antiviral agent that...
US20090136594 Functionalization of Micro-And Nano Particles for Selective Attachment to Calcium Biomineral Surfaces  
The present invention includes compositions, methods, devices and kits for magnetizing a biological particle by contacting a biological particle with a ferrous or magnetic particle that is able to...
US20110166077 COMBINED THERAPY AGAINST TUMORS COMPRISING SUBSTITUTED ACRYLOYL DISTAMYCIN DERIVATIVES AND RADIOTHERAPY  
The present invention provides the use of acryloyl distamycin derivatives, in particular α-bromo- or α-chloro-acryloyl distamycin derivatives, in combination with radiotherapy, for the treatment...
US20140186467 COMPOSITION AND USE FOR ERADICATION OF HIV, TREATMENT OF AIDS AND OTHER DISEASES INCLUDING TUBERCULOSIS IN A HUMAN  
A composition comprising at least one penicillin, at least one iron source, and at least one oil, method of making, and method of use thereof are described. Although suitable for many forms and...
US20090317488 Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof  
A process for preparing a formulation comprising a complex comprising an effective amount of ferrous iron bound to a pharmaceutically acceptable cationic resin and at least one pharmaceutically...
US20120195974 CONTROLLING MEALYBUGS  
The invention disclosed in this document concerns controlling mealybugs.
US20090117168 Device and method for attaracting diseased cells and foreign substances  
An implantable device for attracting diseased cells or foreign substances circulating within bodily fluid channels is disclosed. The device comprises a frame, an attachment means for maintaining...
US20080213345 Delivering Iron to an Animal  
The invention provides a method for delivery iron to an animal. This invention further provides a method for treating iron deficiency in an animal.
US20070292463 COMPOSITIONS AND METHODS COMPRISING ENERGIZABLE PARTICLES FOR HEALTH USE  
The present invention provides a composition comprising a topical composition base and a plurality of particles selected from the group consisting of magnetic particles, particles comprising...
US20100150898 COMPOUNDS AND METHODS FOR THE TREATMENT OF AIRWAY DISEASES AND FOR THE DELIVERY OF AIRWAY DRUGS  
Chronic obstructive airway diseases are treated by administering an osmotically active compound such as a salt, sugar, sugar alcohol, or organic osmolyte to the afflicted airway surface. The...
US20150050261 DIETARY AND NUTRITIONAL SUPPLEMENTS CONTAINING AN OMEGA-3 FATTY ACID OF PLANT-BASED ORIGIN AND A FOLATE DERIVATIVE  
The present invention relates to dietary and nutritional supplements comprising various vitamins, minerals and nutrients, including an omega-3 fatty acid of plant-based origin and a folate derivative.
US20150150800 MINERAL SUPPLEMENTATION OF BEVERAGES  
The present invention is directed to metal supplementation of beverages. More particularly, it is directed to a metal containing complex coacervate core micelle comprising a negatively charged...
US20090035385 COMPOSITIONS INCLUDING IRON  
Compositions and methods for prevent, stabilize, reverse or treat disorders related to iron deficiency in a human or other animal. In a first embodiment, the composition includes about 10 mg to...
US20100330199 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY  
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability...
US20090041858 Haemostatic Compositions Thickened by Polymers Containing Nitrogen Moieties  
The present invention is the development of haemostatic compositions that use nitrogen containing organic polymers in combination with haemostatic agents to create a gel form. Compositions...
US20110294665 BIOACTIVE AGENT, PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, FRESHNESS KEEPING AGENT, AND PLANT AND ANIMAL GROWTH PROMOTING AGENT  
The subject of the present invention is to provide a bioactivator which is useful as a medicine, growth promoting agent for plants and animals, and the like, wherein the bioactive effectiveness of...
US20100135950 Iron(II)-Containing Treatments for Hyperphosphatemia  
A pharmaceutical composition comprises a pharmaceutically acceptable ferrous iron compound; an amine polymer or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable...
US20100303928 ISOXAZOLOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF HIF-MEDIATED CONDITIONS  
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase...
US20150209336 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY  
The present invention relates to novel compounds according to Formula I or II, methods, and compositions capable of decreasing HIF hydroxylase enzyme activity, thereby increasing the stability...
US20100233245 NANOPARTICLE COMPOSITION AND PROCESS THEREOF  
The present invention relates to nanoparticle composition comprising cellulose nanofibers embedded with nanosized material. More particularly the present invention relates to cellulose nanofibers...
US20090304816 METHOD AND COMPOSITION FOR TREATING AND DIAGNOSING RESTLESS LEGS SYNDROME  
A method of treating Restless Legs Syndrome (RLS) comprises the joint administration of an agent selected from dopamine turnover increasing agent and dopaminergic receptor exciting agent, in...
US20100172916 SUBSTITUTED HYDROXYPHENYLAMINE COMPOUNDS  
The present invention relates to new substituted hydroxyphenylamine based modulators of hormone and/or pigment levels, pharmaceutical compositions thereof, and methods of use thereof.
US20130243852 ADJUVANT COMPOSITIONS AND METHODS OF POTENTIATING HDAC INHIBITORS USED TO TREAT VARIOUS DISEASES  
A composition and method for potentiating, sensitizing, and/or amplifying at least one HDAC inhibitor targeting at least one disease in a patient is provided. In one embodiment, the composition is...
US20130108710 Antimalarial Drug Which Contains 5-Aminolevulinic Acid or Derivative Thereof as Active Ingredient  
Provided is an antimalarial drug which is useful for prevention and treatment of infectious diseases caused by malaria parasites. A preventive and/or therapeutic agent for malaria, which contains,...
US20090280191 PREVENTIVE REMEDIAL THERAPEUTIC AGENT FOR PHOSPHORUS IMPAIRMENT, ORAL AGENT FOR ADSORBING PHOSPHATE ION CONTAINED IN FOOD, BEVERAGE AND CHEMICAL, AND PROCESS FOR PRODUCING THEM  
The present invention provides agents for preventing, improving or treating phosphorus-related disorders and oral preparations; agents high in biosafety and phosphorus adsorptive power, which...

Matches 1 - 50 out of 63 1 2 >